Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126111803 | 12611180 | 3 | F | 20160905 | 20160801 | 20160915 | EXP | US-TEVA-680927USA | TEVA | MEISNER A,AUSMAN M,DAGRAEDT B,ZIEMINSKI J. PROBABLE DRUG INTERACTION BETWEEN EVEROLIMUS AND CLARITHROMYCIN. ANNALS OF PHARMACOTHERAPY. | 56.00 | YR | M | Y | 136.00000 | KG | 20160915 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126111803 | 12611180 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 1000 MILLIGRAM DAILY; STARTED 12 DAYS PRIOR TO ADMISSION | Y | 65154 | 500 | MG | BID | ||||||
| 126111803 | 12611180 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | U | 18413 | 40 | MG | ||||||||
| 126111803 | 12611180 | 3 | I | EVEROLIMUS | EVEROLIMUS | 1 | Oral | 10 MILLIGRAM DAILY; STARTED 3 MONTHS PRIOR TO ADMISSION | Y | 0 | 10 | MG | QD | ||||||
| 126111803 | 12611180 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 200 MICROGRAM DAILY; | 0 | 200 | UG | QD | |||||||
| 126111803 | 12611180 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MILLIGRAM DAILY; STARTED 12 DAYS PRIOR TO ADMISSION | 0 | 40 | MG | QD | |||||||
| 126111803 | 12611180 | 6 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | Oral | 25 MILLIGRAM DAILY; | 0 | 25 | MG | QD | |||||||
| 126111803 | 12611180 | 7 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Oral | 1000 MILLIGRAM DAILY; STARTED 12 DAYS PRIOR TO ADMISSION | 0 | 500 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126111803 | 12611180 | 1 | Helicobacter infection |
| 126111803 | 12611180 | 3 | Clear cell renal cell carcinoma |
| 126111803 | 12611180 | 5 | Helicobacter infection |
| 126111803 | 12611180 | 7 | Helicobacter infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126111803 | 12611180 | HO |
| 126111803 | 12611180 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126111803 | 12611180 | Acute kidney injury | |
| 126111803 | 12611180 | Drug interaction | |
| 126111803 | 12611180 | Hyperkalaemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |